enGene Therapeutics Inc.: Form 10-K/A for the period ended Oct 31, 2025
Filed with the SEC on Feb 19, 2026 and accepted by EDGAR at Feb 19, 2026, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-059409. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.